Foresite Capital Management Iv, LLC Pharvaris N.V. Transaction History
Foresite Capital Management Iv, LLC
- $156 Million
- Q3 2025
A detailed history of Foresite Capital Management Iv, LLC transactions in Pharvaris N.V. stock. As of the latest transaction made, Foresite Capital Management Iv, LLC holds 4,778,581 shares of PHVS stock, worth $113 Million. This represents 76.4% of its overall portfolio holdings.
Number of Shares
4,778,581
Previous 4,410,581
8.34%
Holding current value
$113 Million
Previous $77.6 Million
53.59%
% of portfolio
76.4%
Previous 85.48%
Shares
8 transactions
Others Institutions Holding PHVS
# of Institutions
81Shares Held
51MCall Options Held
0Put Options Held
0-
General Atlantic LLC New York, NY8.03MShares$189 Million7.09% of portfolio
-
Ven Bio Partners LLC San Francisco, CA4.64MShares$109 Million78.75% of portfolio
-
Viking Global Investors LP3.65MShares$86 Million0.26% of portfolio
-
Eqt Fund Management S.A R.L.3.42MShares$80.6 Million4.59% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA3.18MShares$74.9 Million25.47% of portfolio
About Pharvaris N.V.
- Ticker PHVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,766,000
- Market Cap $795M
- Description
- Pharvaris N.V., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapies for rare diseases. The company develops PHA121, a small molecule bradykinin B2-receptor antagonist that is in Phase II clinical trial for the treatment of hereditary angioedema (HAE). It also develops PHVS416, an on-demand, r...